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Abstract
In this work we describe a series of improvements to the Salmonella-based salicylate-inducible cascade expression system
comprised of a plasmid-borne expression module, where target gene expression is driven by the Pm promoter governed by
the XylS2 regulator, and a genome-integrated regulatory module controlled by the nahR/Psal system. We have constructed a
set of high and low-copy number plasmids bearing modified versions of the expression module with a more versatile
multiple cloning site and different combinations of the following elements: (i) the nasF transcriptional attenuator, which
reduces basal expression levels, (ii) a strong ribosome binding site, and (iii) the Type III Secretion System (TTSS) signal
peptide from the effector protein SspH2 to deliver proteins directly to the eukaryotic cytosol following bacterial infection of
animal cells. We show that different expression module versions can be used to direct a broad range of protein production
levels. Furthermore, we demonstrate that the efficient reduction of basal expression by the nasF attenuator allows the
cloning of genes encoding highly cytotoxic proteins such as colicin E3 even in the absence of its immunity protein.
Additionally, we show that the Salmonella TTSS is able to translocate most of the protein produced by this regulatory
cascade to the cytoplasm of infected HeLa cells. Our results indicate that these vectors represent useful tools for the
regulated overproduction of heterologous proteins in bacterial culture or in animal cells, for the cloning and expression of
genes encoding toxic proteins and for pathogenesis studies.
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Introduction
In recent years, a range of regulated prokaryotic gene
expression systems have been developed to adapt production
conditions for different requirements. Most systems consist of a
single module containing both an inducible transcriptional
regulator, responsive to an exogenous factor, and an expression
element containing the gene of interest under the control of a
promoter that triggers gene expression in response to the
regulatory element. Successive modifications to existing protein
production systems have been made in order to improve their
performance in aspects such as reducing basal expression without
compromising maximal expression levels, something especially
useful for expressing or cloning genes encoding proteins with
deleterious effects. Mutated promoters and regulators, low gene
dosage and transcriptional attenuation have been extensively
explored in an effort to reduce undesired basal expression levels
[1,2,3,4]. Although the highest levels of recombinant protein
expression are obtained by amplifying gene dosage with high-copy
plasmids, competition between exogenous expression and host cell
metabolism can lead to cell growth inhibition [5]. Growth effects
or low-level toxicity can lead to selection pressure within the
bacterial population for changes, which negatively affect recom-
binant protein expression. The loss of protein expression
competence when the encoding genes are located in multi-copy
vectors represents a major problem in situations where plasmid
selection is not possible, such as regulated protein expression
during bacterial infection.
The efficiency of these single systems may be increased by
coupling at least two transcriptional regulators in a cascade, where
expression of one regulator directs expression of a second
regulator, which in turn directs transcription of the heterologous
gene located at the expression module. These transcriptional
regulatory cascades substantially amplify the amount of protein
produced in natural [6] or artificial systems [7,8]. Expression
systems based on a regulatory cascade have been constructed that
take advantage of the inducing activity of salicylate on two
transcriptional activators derived from Pseudomonas putida: NahR,
from the naphalene degradation plasmid NAH7, and XylS2 from
the toluene/xylene degradation plasmid pWW0 [7,9]. The
binding of salicylate to NahR and XylS2 activates the expression
of genes controlled by the Psal and Pm promoters respectively. The
regulatory module combines nahR with xylS2 under the control of
the NahR-responsive Psal promoter. The gene of interest is
inserted into a separate expression module downstream of the
XylS2-responsive Pm promoter. In the absence of salicylate both
NahR and XylS2 are inactive, resulting in very low basal
expression of Pm-controlled target genes due to low levels of xylS2
expression and the absence of salicylate-dependent XylS2
activation. Conversely, the presence of salicylate strongly activates
target gene expression in two ways, by binding NahR and
activating Psal-xylS2 transcription and then by inducing XylS2 to
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drive Pm promoter-mediated expression. Expression systems based
on XylS2 and NahR have been shown to have low basal
expression levels together with very high inducing ratios and stable
levels of expression [7,8]. By inserting single copies of both
regulatory and expression modules into the host strain chromo-
some, we have shown that it is possible to stably drive protein
expression for several days even without selective pressure, unlike
high-copy plasmid based systems [7].
To further reduce basal expression levels, an additional
regulatory circuit was also incorporated into this system, consisting
of two elements from Klebsiella oxytoca involved in nitrate
assimilation, nasF, a transcriptional attenuator [10,11,12,13] and
nasR, which encodes the corresponding antiterminator protein that
prevents nasF transcriptional termination in the presence of nitrate
or nitrite. Incorporation of nasF downstream of the Pm promoter
reduces basal transcriptional levels from the expression module
[3]. By including a Psal promoter-controlled nasR module on an
additional plasmid, salicylate-induction activates the Pm-promoter
via activation of NahR and XylS2 and at the same time alleviates
nasF-mediated transcriptional termination via NahR-driven nasR
expression. This regulatory circuit has been successfully tested on
Salmonella enterica serovar Typhimurium to selectively switch on
gene expression during bacterial infection [14]. This system also
presents the advantage that it can be induced by acetyl salicylic
acid (ASA) [14], one of the most widely used and best-
characterized analgesic and anti-inflammatory drugs available
[15]. Salmonella is an enteric bacterial pathogen that causes a
variety of food and water-borne diseases, commonly used as a
model to study host-pathogens interactions. Here we demonstrate
a series of improvements to the original configuration of the
regulatory module by coupling the antiterminator gene nasR with
Psal/xylS2 on the regulatory module, as well as cloning a
constitutively-expressed GFP encoding gene downstream. Addi-
tionally, we have developed a series of low and high-copy plasmids
bearing modified expression modules. Each vector has a particular
combination of basal expression level and fully induced level by
salicylate or acetyl salicylate, and together they cover a wide range
of basal and induced levels of expression. These modifications are
useful for a variety of purposes such as providing different
expression levels and induction ratios under the same induction
conditions by choosing the appropriate vector, tracking bacteria
during infection studies, or translocating induced proteins to the
eukaryotic cytosol.
Results
Construction of a Salmonella strain bearing a new
regulatory module in its chromosome to overproduce
heterologous proteins
The salicylate inducible cascade expression system allows the
regulated intracellular expression of proteins in Salmonella [14]. We
have improved on the regulatory module in two ways: (i) nasR was
introduced downstream of xylS2 to coordinate transcription of the
activator and antiterminator proteins and avoid the requirement
for two plasmids; (ii) a gfp gene transcribed from a Ptac promoter
was inserted downstream the regulatory module to track Salmonella
during the infection process, as a tool to study host-pathogen
interactions [16,17,18]. Ptac-gfp is preceded by a strong transcrip-
tion terminator [19] to prevent read-through transcription from
the regulatory xylS2 and nasR genes, since high levels of GFP in
Salmonella can reduce their ability to infect eukaryotic cells [20]
(Figure 1).
The new regulatory module was inserted into the trg locus of
Salmonella enterica serovar Typhimurium strain 14028 chromosome
to create the strain MPO96. This locus was selected because it
encodes a ribose/galactose chemoreceptor described as non-
essential for bacterial pathogenesis [21].
Expression vectors design
Since Salmonella does not metabolise the inducer, its
concentration can be kept constant in the culture medium
and it is possible to obtain different expression levels with the
same expression vector in Salmonella cultures by using different
inducer concentrations [9]. However, controlling a particular
expression level in an animal model by maintaining constant an
intermediate inducer concentration inside the animal is very
difficult, above all considering that the inducer is metabolised
by the eukaryotic cells. Reproducible control of different
expression levels can be obtained by using a saturating inducer
concentration and plasmids whose fully induced expression
levels were different [22]. To control different expression levels
and to obtain a wide range of basal and induced expression
levels, we have constructed a set of vectors that produce
different levels of protein under the same induction conditions
(Table S1).
First, we improved the Multiple Cloning Site (MCS) of the
previous multi-copy expression vector pMPO27 [3] with the
addition of new restriction sites and the elimination of duplicated
ones, thus generating plasmid pMPO57 (MCSII). The whole
fragment comprising the rrnBT1T2 terminators, the Pm promoter
and the MCSII is flanked by NotI restriction sites, allowing for the
easy transfer of cloned genes between vectors. A synthetic DNA
fragment containing the T7 Shine-Dalgarno (SD) sequence and
the upstream A+T rich leader was introduced into pMPO57 to
construct plasmid pMPO58. An NdeI site downstream of the T7
SD incorporates an ATG start codon can be used to insert coding
sequences of interest in-frame. Plasmids pMPO51 and pMPO52,
lacking the nasF attenuator, were generated from pMPO57 and
pMPO58 respectively.
We generated low-copy number versions of these plasmids using
the pWSK29 derivative pMPO20 (pMPO54, pMPO55, pMPO60
and pMPO61, respectively) (Figure 2 and Data S1).
Vectors bearing the T7 SD sequence were additionally modified
to include the 59 terminal 450 nucleotides of sspH2, thus
generating plasmids pMPO53, pMPO56, pMPO59 and pMPO62
(See Figure 2 and Data S1). SspH2 is an effector protein of
Salmonella, which is secreted to the eukaryotic cytoplasm through
the Type III Secretion System (TTSS) of the Salmonella
Pathogenicity Island 2 (SPI 2). Fusion with this N-terminal signal
peptide is sufficient to direct proteins secretion to the eukaryotic
cytoplasm [23,24].
Finally, we constructed an additional plasmid, pMPO1003
(Data S1), containing the MCSII and a sequence encoding the HA
Figure 1. Organization of the improved regulatory module
integrated at the trg locus of the Salmonella chromosome. Boxes
represent genes and arrowheads represent promoters. Hairpin repre-
sents the histidine operon transcriptional terminator from Salmonella
(His-T). nasR and xylS2 are coupled in the same transcriptional unit.
nahR and xylS2/nasR are differentially transcribed from Pnah and Psal
respectively. gfp is transcribed from Ptac.
doi:10.1371/journal.pone.0023055.g001
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epitope under the control of the Pm promoter. This plasmid can be
used for the construction of fusion proteins to detect its secretion
into eukaryotic cytoplasm using an anti-HA antibody (see below).
Gene expression rates of the new vectors
In order to test the functionality of the new elements included in
the expression and regulatory modules (T7 SD sequence,
attenuator, NasR and low gene dosage), we constructed lacZ
translational fusions in our vectors bearing the T7 SD sequence.
To compare expression levels obtained from T7 SD to those
obtained with a different SD, we cloned the previously described
cat-lacZ translational fusion into vectors lacking the T7 SD [25].
Both types of fusions were also transferred to the low-copy number
plasmid pMPO20. Thus, we constructed a plasmid collection
containing lacZ translational fusions with or without nasF
attenuator, with T7 or cat SD sequences and in high or low-copy
number (Table 1 and Data S1). The ß-galactosidase assays were
performed using the Salmonella strain MPO96, which expresses
nasR from the chromosomally-integrated regulatory module.
The results shown in Table 1 indicate that there was
considerable variation in the range of basal or induced levels of
protein production between different vectors. The highest level of
ß-galactosidase activity following induction (77,608 Miller Units)
was obtained using the multi-copy vector lacking the nasF
attenuator and bearing the T7 SD sequence. In this case the
expression level was 18-fold higher than the lowest induced level,
obtained with the low-copy configuration bearing the attenuator
and lacking the T7 SD. In general, the vectors carrying T7 SD
achieved induced activity levels 4 to 10-fold higher than their
respective counterparts bearing the cat SD.
As expected, the nasF attenuator substantially reduced basal
expression levels in all vectors. However, upon induction, vectors
bearing the attenuator strongly expressed lacZ, at levels approx-
imately 70% of their respective counterparts lacking the
attenuator. Expression from nasF attenuator vectors could be
further increased by nitrate addition, resulting in maximal
expression levels broadly equivalent to those from vectors lacking
the attenuator. These results suggest that NasR produced from the
chromosomal regulatory module is effective in preventing
transcription termination at the nasF attenuator.
The best induction ratios (above 100-fold) were obtained with
the low-copy number vectors bearing the nasF attenuator.
Interestingly, the highest expression level from the low-copy
number vector was comparable to that of its corresponding high-
copy number vector (See values of ß-gal activitiy obtained with
plasmid pMPO1008 versus plasmid pMPO1007 in table 1). This
result indicates that using lacZ as a reporter gene the use of low-
Figure 2. Organization of the different expression modules. (A)
Schematic diagram of the different elements of the expression module.
rrnBT1T2, terminators of ribosomal RNA operons; Pm, Pm promoter;
nasF, transcriptional attenuator; SD T7, Shine-Dalgarno sequence from
pT7-7; sspH2, type three secretion system signal peptide; MCSII,
multiple cloning site. Letters correspond to restriction enzyme sites:
Nt, NotI; E, EcoRI; Sm, SmaI; N, NdeI; P, PstI; EV, EcoRV; Nc, NcoI; K, KpnI;
Sa, SacI; B, BamHI; Sl, SalI; H, HindIII. (B) Combinations of the main
characteristics of the vectors described in this work.
doi:10.1371/journal.pone.0023055.g002
Table 1. ß-galactosidase expression levels and induction ratios obtained with the different expression vectors in the strain MPO96.
Name Copy number Nas F SD Expression level (Miller Units) Induction ratio
No induced +Sal +Sal+NO3 +Sal +Sal +NO3
pMPO94 High Yes cat 177634 1313361999 142466898 74 80
pMPO96 High No cat 944655 1759363807 1738061180 19 18
pMPO1000 Low Yes cat 59619 43086290 915661402 73 154
pMPO1001 Low No cat 297633 72096258 71446377 24 24
pMPO1007 High Yes T7 19506212 7688369661 7557664889 39 39
pMPO1005 High No T7 85726482 7760865719 7361565729 9 9
pMPO1008 Low Yes T7 6626183 4932661653 7104164324 75 107
pMPO1006 Low No T7 42036715 7012564676 7216764282 17 17
MPO96 bear the nasR in the regulatory module. Salicylate induces transcription initiation from the Pm promoter, whilst nitrate activates antitermination activity of NasR.
Results show the average of three independent experiments.
doi:10.1371/journal.pone.0023055.t001
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copy vectors increases regulatory capacity without compromising
maximal levels of protein production.
To confirm the effectiveness of chromosomally-produced NasR
in counteracting nasF transcription attenuation, we assayed lacZ
expression in absence or presence of the attenuator in MPO96 and
its isogenic NasR2 strain MPO94 (Figure 3) using the low copy
plasmids bearing the T7 SD sequence (pMPO1006 and
pMPO1008). In the absence of nasR, salicylate-induced expression
from the nasF attenuator vector was 33.4% of that from the vector
lacking it and this expression did not change in the presence of
nitrate. However, in the NasR+ strain, the addition of salicylate
increased lacZ expression, and was further enhanced by the
presence of nitrate up to the levels obtained with the vector lacking
nasF in the same strain. Thus, the increased expression following
nitrate addition is dependent on NasR. In addition, our results
show that a single chromosomal copy of NasR under Psal control is
sufficient to block nasF attenuator transcriptional termination.
In summary, these results show that using the same induction
conditions, this regulatory cascade can produce different amounts
of the same protein, depending on the particular features of the
expression vector.
Cloning the colE3 gene in the expression vectors
Obtaining the lowest possible levels of basal expression is critical
when the protein of interest is toxic for the host bacteria.
Significant basal expression of a protein that adversely affects
bacteria growth or survival is likely to drive selection within the
bacterial population for mutant bacteria that do not express a
functional protein.
To determine if our vectors have sufficiently low levels of basal
expression to allow the cloning of highly cytotoxic genes, we
attempted to clone colE3 (Data S1). This gene codes for colicin E3,
a ribonuclease that is cytotoxic to a number of enterobacteria.
Strains that naturally produce colicin E3 are protected by the co-
expression of the immunity protein ImmE3 [26].
We tried to clone a DNA fragment carrying the colE3 gene
under the control of Pm in multi-copy vectors, with or without the
nasF attenuator, in an ImmE3+ E. coli strain [27]. In spite of the
repeated attempts, no colonies whatsoever were obtained with the
vector lacking the attenuator, suggesting that basal expression
levels obtained from high-copy number plasmids in the absence of
the attenuator are sufficiently high to be toxic even in the presence
of its immunity protein. In contrast, numerous colonies were
obtained when the ImmE3+ E. coli strain was transformed with a
nasF-regulated multi-copy vector (pMPO1009).
Interestingly, similar numbers of clones were obtained when
ImmE3+ E. coli were transformed with low-copy colE3 plasmids
with or without the nasF attenuator (pMPO1011 and pMPO1010
respectively). This result indicates that, in the presence of the
immunity protein, low gene dosage reduces the basal expression of
colicin to a level that allows colE3 cloning irrespective of the
attenuator.
Maintenance of the colicin production ability in the
absence of ImmE3
Next we decided to test the ability of the nasF attenuator to
reduce basal expression sufficiently to allow the induced
expression of toxic proteins in ImmE32 Salmonella. To this end
we assayed the capability of the new vectors to produce colicin
following salicylate induction both in ImmE3+ (MPO316) and
ImmE32 (MPO96) Salmonella strains. Transformed Salmonella
were cultured with antibiotic selection and spotted on plates in the
presence or absence of salicylate (Figure 4). Strains transformed
with colE3 in multicopy plasmids bearing the nasF attenuator
showed impaired growth even in the absence of salicylate, as
evidenced by the smaller size of their colonies (Figure 4A).
Nevertheless, their viability was not compromised since the
number of colonies was similar to the control strain transformed
with the empty vector. Salicylate induction resulted in the death
of the majority of the bacterial population irrespective of the
immunity, suggesting that a strong colicin producing capacity had
been retained. Only a few colonies tolerated salicylate induction
(with a frequency lower than 1025), which presumably represent
bacteria (e.g. spontaneous mutants) that produce lower amount of
colicin E3 despite antibiotic selection. This observation indicates
that the presence of the attenuator reduces basal colicine
production sufficiently to maintain cell viability, even in the case
of multi-copy plasmids.
Figure 3. ß-Galactosidase activity in Salmonella strains carrying nasR. Strain MPO96 with the nasR containing chromosomal regulatory
module and MPO94 with the non-nasR containing version. Strains harbored plasmids with (pMPO1008) or without (pMPO1006) the nasF attenuator.
Black bars, not induced; white bars, salicylate induced; grey bars, induced by salicylate plus nitrate. Error bars correspond to Standard Deviation. The
results show the average of three independent experiments.
doi:10.1371/journal.pone.0023055.g003
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Bacteria transformed with the low-copy number plasmid
carrying the nasF attenuator (pMPO1011) generated healthy
fast-growing colonies even in the absence of the immunity immE3
gene (Figure 4B). Moreover, induction with salicylate killed most
of the bacterial population, indicating that the basal expression
level had been low enough to allow plasmid-containing bacteria to
grow without selecting against colicin production capacity, even in
an ImmE32 strain, yet upon induction was able to reach an
expression level sufficient to overcome the immunity.
In the absence of the nasF attenuator (pMPO1010) most
ImmE3+ bacteria retained colicin production capacity upon
induction; albeit with a low frequency (#1025) of bacterial
survival, presumably corresponding to bacteria with impaired
colicin production. However, growth of the ImmE32 strain was
clearly affected even in the absence of salicylate. Interestingly,
while most colonies were very small, some large colonies were also
evident. Growth in the presence of salicylate indicated that a
significant proportion of the population (1022–1023) had been
deficient for colicin production. Presumably, the large colonies in
the medium lacking salicylate reflect the appearance of bacteria
lacking the ability to produce the toxin.
Taken together our data indicate that, the combination of the
nasF attenuator and low copy plasmids permits bacterial growth
while retaining the ability to produce toxic proteins. Interestingly,
our findings suggest that the increased basal expression in the
absence of nasF corresponds to increased selection against
production-competent bacteria.
Maintenance of colicin production capacity in the
absence of selective pressure
In situations where antibiotic selection cannot be used to
maintain the plasmids, such as in cell culture or animal models, the
presence of a toxic protein is likely to quickly drive selection for
plasmid loss or otherwise lose the ability to produce the toxin. To
test whether the reduced basal expression of our expression vectors
was sufficient to overcome this type of negative selection, Salmonella
bearing salicylate-inducible colE3 plasmids were grown for 20
generations without antibiotic selection, followed by testing for
plasmid maintenance and colicin production.
As shown in Figure 5, at least 90% of the bacterial population
harboring the high-copy vector with the attenuator (pMPO1009)
had lost the plasmid and their ability to produce colicin, even
when transformed into the immunity-bearing strain. In contrast,
the low-copy plasmid lacking the attenuator (pMPO1010) was
stably maintained by the ImmE3+ strain and kept its response to
salicylate induction intact. However, most ImmE32 bacteria had
lost this plasmid (.95%) and did not die upon salicylate induction
(100% of the population). Remarkably, when the low-copy colicin-
producing plasmid incorporated the nasF attenuator (pMPO1011),
the majority of the bacterial population maintained the plasmid
and died upon salicylate induction (95 to 99%), even in the
absence of the immunity protein. These data show that changes in
basal expression can dramatically affect the retention of expres-
sion-module containing plasmids. Moreover, our results suggest
that the combination of a low-copy vector and the presence of the
nasF is able to reduce basal expression below the selection
threshold in highly sensitive ImmE3- Salmonella, even in the
absence of positive antibiotic plasmid selection.
Expression in gfp-tagged Salmonella while infecting
eukaryotic cells
To monitor infection and to detect Salmonella inside the
eukaryotic cells, the gfp encoding sequence under the control of
the strong Ptac promoter was inserted downstream of the regulatory
Figure 4. Maintenance and expression of colicine from different plasmid configurations in Salmonella. Serial dilutions (103 to 107) of
cultures of strains MPO96 and MPO316 expressing colE3 from high-copy number (A) and low-copy number (B) vectors were plated in LB with or
without salicylate and incubated for 24 hs.
doi:10.1371/journal.pone.0023055.g004
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module in the same trg locus of Salmonella (see Figure 1). As shown
in Figure 6, the strain MPO96 produces enough GFP for detection
by fluorescence microscopy or flow cytometry (Figure 6 A,B),
while a control strain lacking GFP does not (Figure 6 C,D).
To quantify the global induction efficiency of the cascade
expression system in cell culture, we infected HeLa cells with
Salmonella strain MPO94 bearing a plasmid (pMPO1046) carrying
the dTomato red fluorescent protein encoding gene under Pm
promoter control. Infected HeLa cultures were induced with
salicylate and analyzed by fluorescence microscopy. As shown in
Figure 7A–C, the production of the red dTomato protein was
limited to those cells infected by Salmonella. Quantification by flow
cytometry confirmed this result, with 70–80% of GFP positive
bacteria expressing the red fluorescent protein upon salicylate
induction (Figure 7E), while in the absence of salicylate such
expression could not be observed (Figure 7D).
To test the maintenance of cytotoxic protein production capacity
when used to infect animal cells, HeLa cultures were infected with
an ImmE32 NasR+ Salmonella (strain MPO96) bearing a low-copy
Pm-nasF attenuator-colE3 plasmid (pMPO1011). One hour or
24 hours after infection, colicin production was induced by addition
Figure 5. Plasmid stability and expression of functional
colicine without antibiotic selection. Percentage of bacteria that
retain plasmids (white bars, ampicillin resistance), and salicylate-
induced death by accumulation of colicin E3 (grey bars) after 20
generations of growth in non-selective medium. MPO96 - Salmonella
strain lacking immE3 gene. MPO316 - isogenic ImmE3+ strain.
pMPO1009 - high-copy plasmid bearing the attenuator; pMPO1010
and pMPO1011 - low-copy number plasmids that lack or bear the
attenuator, respectively. Error bars represent the average of four
independent experiments.
doi:10.1371/journal.pone.0023055.g005
Figure 6. Salmonella detection by microscopy and flow cytometry analysis. Visualization of HeLa cells infected with the MPO96 (A) or 14028
(C) strains using the Confocal Microscope Leica SPE (630X). MPO96 strain express GFP (green) while 14028 strain does not. Eukaryotic nuclei and
bacterial DNA (blue) were stained with Hoescht and eukaryotic cytoskeleton (red) with rhodamine-phalloidine. All the channels were taken at the
same Z plane (Z = 4.5 mm in A or 0.3 mm in C). Scale bar is indicated in the left. Fluorescence of HeLa cells infected with the MPO96 (B) or 14028 (D)
strains by flow cytometry analysis. The right peak on B represents the infected cells while the left peak represents the non infected cells. The number
above the left peak represents the percentage of non-infected cells. Samples were collected 1 h.p.i. for microscopy and flow cytometry analysis.
Results show the average of three independent experiments.
doi:10.1371/journal.pone.0023055.g006
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of salicylate. At different time points after the infection (1, 24 and
48 hours), infected cells were detached and lysed to count the
number of intracellular bacteria. As shown in Figure 8A (upper
panels), the combination of the attenuator and low gene dosage
permitted bacterial infection and growth in the absence of salicylate.
In contrast, the expression of colicin after salicylate induction
resulted in bacterial death (lower panels). As shown in Figure 8B, the
number of recovered intracellular bacteria remained constant in
absence of salicylate. Additionally, the number of bacteria obtained
was similar when lysed cultures were plated on LB and LB
ampicillin, indicating that the bacteria maintained the plasmid after
several hours of growth inside the eukaryotic cell. However, upon
salicylate induction the number of c.f.u. decrease significantly
showing that bacteria maintain the colicin production capacity at
least 24 h after infection. These results are in agreement with those
obtained in isolated bacterial cultures, and confirm that the
regulated production of toxic proteins can be maintained during
the infection process in the absence of selective pressure and
antitoxin proteins.
Regulated Salmonella protein secretion into the
eukaryotic cell cytoplasm
To test if the SspH2 leader peptide cloned in some vectors is
able to direct the secretion of fusion proteins from Salmonella to the
eukaryotic cytosol, the sequence coding for the HA epitope was
cloned in the high-copy number, Pm-T7 SD-sspH2 plasmid
(pMPO53) to generate plasmid pMPO1004. Production of
SspH2-HA and its subcellular location were tested in HeLa cell
cultures infected with MPO94 containing the pMPO1004
plasmid. As shown in Figure 9A, SspH2-HA was produced by
intracellular bacteria after salicylate induction, and secreted into
the eukaryotic cell cytoplasm, while in the absence of salicylate the
secretion could not be detected (Figure 9C). Quantification of the
SspH2-HA fusion protein revealed that 75% of the product was
translocated to the eukaryotic cytoplasm only in the presence of
salicylate (Figure 9B and D). In contrast, a control strain lacking
the sspH2 sequence in the plasmid was unable to translocate HA
(data not shown).
Discussion
In this work we present modifications that improve the
performance of the previously described Pm-nasF NahR-XylS
regulatory cascade expression system at two levels: (i) the
regulatory module has been modified to include nasR under Psal
control and a constitutively expressed gfp to allow bacterial
infection to be followed; (ii) the expression module has been placed
in high and low-copy number plasmids, which were modified to
obtain more versatile expression vectors.
The cascade regulatory circuit has been successfully used to
express proteins in E. coli [3,7,8], but since Salmonella enterica offers
additional possibilities such as regulated expression inside animal
cells [14], we have modified the system to adapt it for alternative
uses in these bacteria, particularly for its use within animal cells.
For this purpose we integrated the new regulatory module into the
Salmonella chromosome at the trg locus, described as non-essential
for invasiveness or proliferation [21]. In this module nasR and
xylS2 are simultaneously induced by salicylate, avoiding the use of
two different plasmids [3]. Although the copy number of the
antiterminator nasR is reduced in this chromosomal location as
Figure 7. Inducible intracellular expression of dTomato protein. HeLa cells cultures were infected with Salmonella MPO94 harbouring
pMPO1046 plasmid (100X), induced for 4 hs with 2 mM salicylate and processed for fluorescence microscopy or flow cytometry analysis. Visualization
of GFP fluorescence (A), dTomato protein (B), and merge (C) is shown. (D), cytometric analysis of infected and (E) infected and induced cells. R1, not
infected cells; R2, Infected cells; R3, Infected and induced cells. Results show the average of three independent experiments.
doi:10.1371/journal.pone.0023055.g007
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Figure 8. Expression of colicine inside eukaryotic cells. (A) Visualization of HeLa cells (320X) infected by Salmonella MPO96 strain bearing
plasmids pMPO20 and pMPO1011 under inducing or no inducing conditions. (B) Bacteria recovered from infected cells at different times post-
infection. The absence of GFP inside cells corresponds to bacterial death as demonstrate the decrease of bacteria recovered after salicylate induction.
N.I., not induced; +Sal, addition of salicylate at 1 h.p.i.; +Sal 24 to 48 h, addition of salicylate at 24 h.p.i; h.p.i., hours post-infection. Arrows indicate the
time of salicylate addition, at 1 h (black) and 24 h (green) post-infection. The data showed in panel A correspond to one representative experiment
out of four.
doi:10.1371/journal.pone.0023055.g008
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compared to the plasmid location, it appears that a single copy of
nasR is sufficient to achieve efficient antitermination of nasF.
(Table 1 and Figure 3).
GFP production from a single copy Ptac promoter did not affect
performance of the strain (data not shown) but was sufficient to
track bacteria during infection processes by microscopy or flow
cytometry analysis (Figure 6). This tool offers the possibility of
quantifying the fluorescence at different stages of infection, serving
as a measure of bacterial proliferation inside eukaryotic cells.
Modifications to the expression module in both low- and high-
copy vectors include a more versatile multicloning site, a strong
SD sequence to drive efficient translation, a transcriptional
attenuator from the nasF operon to reduce basal expression levels,
and the sspH2 signal peptide sequence to secrete proteins through
the TTSS. With these vectors, we could obtain high induction
ratios (Table 1). Moreover, it was possible to obtain different
expression levels under the same fully inducing conditions by
choosing vectors with different copy numbers or SD sequences
with different translation efficiencies [28].
For applications involving the expression of proteins with
deleterious effects on the producing bacteria, it is essential that
basal expression be tightly-controlled under non-induced condi-
tions to permit the stable maintenance of their expression ability.
The low-copy number vectors containing the nasF attenuator
reduce basal expression level so efficiently that they allowed the
maintenance and regulated expression of the cytotoxic colE3 gene
in a Salmonella strain even in the absence of the immunity protein
that prevents its function (Figure 4). In spite of this, the maximal
level of induced expression was not compromised (Table 1). The
stable maintenance of colicin-expressing low copy plasmids in the
absence of their cognate immunity protein system has been
described previously using a system based on the lactose
promoter/operator [2]. However, this system presents the
disadvantage that as it uses a negative control system, meaning
that there is transient target gene expression upon transformation
until the repressor, encoded in the same plasmid, has time to be
produced in sufficient quantities. In contrast, the regulatory
cascade described here uses a positive control system, whereby
expression is dependent on the presence of salicylate.
Using the 59 region of sspH2, we have developed expression
vectors able to translocate fusion proteins into the eukaryotic
cytoplasm (Figure 9). Such translocation depends on the secretion
system located in SPI-2 that is only activated under intracellular
conditions [29]. Although it has been hypothesized that the
overexpression of chimeric SspH2 could saturate the TTSS
translocation machinery [30], our result clearly indicates that the
translocation capacity of the system is sufficiently high to secrete
around 75% of the product generated by this expression system in
infected cells.
In addition, we have developed a plasmid (pMPO1003) that can
be used to study protein secretion based on the immunodetection
of the commonly used HA epitope. This plasmid is conceived for
the construction of chimeras with putative effector proteins in
order to evaluate their translocation and co-localization. Different
systems based on secretion and quantification of b-lactamase
cleavage of a specific fluorescent substrate have been previously
described to detect protein translocation [31], but its use is
technically more difficult due to the instability of the product.
It has been previously reported that in animals Salmonella
preferentially accumulates in the tumours of affected animals
[32,33]. The combination of controlled production of cytotoxic
proteins with the ability to direct its translocation into the
eukaryotic cytosol using a TTSS, suggests that this system has the
potential to be excellent tool for the delivery of therapeutic drugs
into tumors. The regulatory module has been inserted in the trg
locus, whose mutation does not affect pathogenesis. Interestingly,
it has been recently reported that a Trg2 Salmonella accumulated in
the tumour quiescence area and had a higher apoptotic effect on
infected cells than a wild type strain [34].
In summary, we present here a series of improvements to the
salicylate-based NahR-XylS2 cascade expression system that show
great potential for applications in different research areas, such as
cloning toxic proteins from different origins, studies of Salmonella
pathogenesis by expressing genes at different stages during
infection, assaying the translocation of putative effector proteins,
and specifically targeting the delivery of cytotoxic drugs into
tumours.
Materials and Methods
Strain, plasmids and growth conditions
All plasmids and bacterial strains used in this work are described
in the table S1. Cultures were grown aerobically at 180 r.p.m. and
37uC in LB medium and supplemented when necessary with
ampicillin (100 mg/ml), kanamycin (20 mg/ml) or chlorampheni-
col (15 mg/ml).
Molecular biology general procedures
All DNA manipulations were performed following standard
protocols [35]. The sspH2 signal peptide and the dTomato genes
Figure 9. Regulated protein secretion in Salmonella through the
type three secretion system (TTSS). Secretion of the HA epitope-
containing chimeric protein through TTSS (1000X) in the presence (A) or
absence of salicylate (C). Salmonella strain MPO94 bearing the
pMPO1004 plasmid, constitutively expressing GFP (green), HeLa cell
nuclei were stained with Hoescht (blue) and anti-HA epitope antibody
staining (red). (B) Western blot of supernatant (S) and pellet (P) fractions
of HeLa cell cultures infected with the Salmonella MPO94 strain bearing
the pMPO1004 plasmid in the presence of salicylate or (D) its absence.
The HA epitope and the bacterial chaperone DnaK were detected with
their corresponding antibodies. The data showed correspond to one
representative experiment out of four.
doi:10.1371/journal.pone.0023055.g009
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were PCR-amplified using genomic DNA from Salmonella or
pRSETB dTomato plasmid as templates, respectively, and primers
sspH2–1 (59 gatatacatatgccctttcatattggaag 39) and sspH2–3 (59
tatactgcagcccggatgccccttc 39) or Tomato-NdeI F (59 tacatatggt-
gagcaagggcgagg 39) and Tomato-HindIII R (59 taaagcttttacttgta-
cagctcgtcc 39) respectively. PCR was performed with High-Fidelity
polymerase (Roche) as directed by the manufacturer. The MCSII,
T7 SD sequence and the 2xHA-epitope, were constructed by
cloning two annealed complementary oligonucleotides (73, 39, and
63 nucleotides long, respectively) into appropriate vectors. The HA
(human influenza hemaggulitin) epitope tag is well-characterized
and highly immunoreactive whose recognized sequence is
YPYDVPDYA. The oligonucleotides sequences are detailed below.
MCS+ (59 gttcacccgggcatatggcaagaactgcagatatccatggtaccgagct-
cggatccgtcgacaagcttacttg 39) MCS- (59 caagtaagcttgtcgacggatcc-
gagctcggtaccatggatatctgcagttcttgccatatgcccgggtgaac 39)
SD pT7-7+ (59 gggaaataattttgtttaactttaagaaggagatataca 39)
SD pT7-72 (59 tatgtatatctccttcttaaagttaaacaaaattatttccc 39)
Sal-HA-Hind+ (59 tcgacgtacccatacgatgttcctgactatgcgtacccatac-
gatgttcctgactatgcgtaa 39)
Sal-HA-Hind2 (59 agctttacgcatagtcaggaacatcgtatgggtacgcatagt-
caggaacatcgtatgggtacg39)
Determination of ß-galactosidase activity
The plasmids pMPO94, pMPO96, pMPO1005, pMPO1007
(high-copy number) and pMPO1000, pMPO1001, pMPO1006 and
pMPO1008 (low-copy number), were used to transform Salmonella
strains MPO94 and MPO96. After growing overnight in LB with
ampicillin as necessary, cultures were diluted 50-fold in the same
media, and allowed to grow to OD600 0.2–0.3 before inducing with
2 mM salicylate and in some cases 0.2 g/l sodium nitrate. 2 mM
salicylate is within the therapeutic concentration in blood [22] and is
sufficient to fully induce the expression system [14]. All cultures
were incubated at 37uC and 180 r.p.m. for 3 h after which ß-
galactosidase activity was measured as described [36].
Survival of bacterial populations upon overproduction of
colicin E3
To determine the effect of producing colicin E3, Salmonella strains
MPO96 and MPO316, were transformed by electroporation with the
plasmids pMPO57, pMPO1009, pMPO20, pMPO1010 and
pMPO1011, grown overnight and diluted 50-fold until OD600 0.5–
0.6 was reached. Bacterial survival frequency was estimated by
plating spots of different dilutions of the cultures on LB plates alone or
with 2 mM salicylate, and estimating growth after incubation for
24 h at 37uC. To estimate the maintenance of colicin production
capacity in the absence of selective pressure serial batch cultures were
performed as follows. Bacteria were inoculated overnight in the
presence of ampicillin; cultures were then diluted 100 fold every
12 hours three times in fresh LB medium. Finally, samples were
collected at 0.8 OD600 (20 generations estimated), diluted and plated
in LB, LB with ampicillin and LB contaning 2 mM salicylate plates.
The proportion of plasmid containing bacteria was calculated as c.f.u.
obtained in LB with ampicillin respective to LB. The population of
bacteria expressing colE3 was calculated as c.f.u. obtained in LB plates
minus c.f.u. obtained in LB salicylate plates.
Regulatory module integration into the Salmonella
chromosome
To integrate DNA sequences into the Salmonella chromosome we
used a modification of the method published by Datsenko and
Wanner [37] to inactivate chromosomal genes in E. coli, as
described in [14]. Kanamycin or chloramphenicol resistance genes
were cloned into plasmids bearing the sequences to be integrated
at the chromosome (pMPO64, pMPO83 and pMPO1035). Since
this new regulatory module is longer than 7 kb, the integration was
made sequentially. As a first step, nahR/XylS2-Cm was integrated
into the trg locus of the Salmonella chromosome. Later, in two
sequential steps, nasR and Ptac-gfp were added at the regulatory
module downstream from xylS2. Finally, the Cm resistance gene
was changed to Km, generating the MPO96 strain. Alternatively,
nasR was deleted to obtain the MPO94 strain.
In vitro bacterial infection of HeLa cells
HeLa cells were grown at 37uC and 5% CO2 in tissue culture
plates (Nunc) in Dulbecco’s modified Eagle’s medium (DMEM;
Sigma) supplemented with 2 mM L-glutamine and 10% Foetal
Calf Serum (FCS) containing a Penicillin-Streptomycin mixture.
Infection experiments were performed essentially as described
[38] with minimal modifications. Cells were cultured in 24-well
plates at a density of 26105 cells per well 20 hours before infection.
An overnight Salmonella culture was diluted 1:33 on fresh LB and
incubated at 37uC during 3.5 h. Cells were equilibrated for 15 min
in Earle’s buffered salt solution (EBSS) before infection. Bacteria
were added at a m.o.i. of 50:1 allowing the infection to proceed for
15 min at 37uC and 5% CO2. Wells were washed twice with
Phosphate Buffer Saline (PBS) and incubated for 1 hour with
DMEM containing 100 mg/ml gentamicin to kill extracellular
bacteria. After that, the antibiotic concentration was reduced to
16 mg/ml. Bacterial induction was performed as described for
bacterial cultures, adding 2 mM salicylate to the culture medium
and incubating for an additional 4 h. For enumeration of
intracellular bacteria, cells were PBS washed, lysed with 0.1%Triton
X-100 for 10 minutes and plated on to LB or LB with ampicillin.
An inverted fluorescence microscope (Leica Systems) was used to
directly visualize infected cells. For quantitative analysis, cells were
detached with trypsin and analyzed by flow cytometry using a
FACScalibur cytometer and CellquestPro software (Becton-Dick-
inson). When necessary, cells were fixed in 4% Paraformaldehyde
(PFA) for 20 minutes at room temperature. Cells were then rinsed five
times in PBS and incubated with Hoescht and rhodamine-phalloidine
for one hour at room temperature. Samples were mounted on glass
coverslips and visualized with a confocal microscope Leica SPE.
Microscopy Assay for translocation of proteins into live
eukaryotic cells
Cells previously infected with MPO94 bearing pMPO1004 were
induced as described before. After 4 h cells were washed and fixed
with PFA 4% during 30 min, permeabilized with 0.1% triton X-
100, and incubated for 45 min with blocking buffer (3% FCS in
PBS) to inactivate HeLa membrane receptors. Cells were then
incubated with 1:500 anti-HA primary antibody (COVANCE) in
blocking buffer overnight. Cells were then washed and incubated for
90 min with a 1:300 dilution in PBS of anti-Mouse IgG conjugated
to Alexa555 secondary antibody (Molecular Probes/Invitrogen). To
stain cellular nuclei, Hoescht was added 20 min before washing.
Preparations were thoroughly washed with PBS before visualizing
by microscopy. Translocation was considered positive when the
fluorochrome-conjugated secondary antibody (red) was clearly
visible in the cellular cytoplasm outside the bacteria (green).
Western blot analysis to test bacterial protein secretion
into live eukaryotic cells
Cells previously infected with MPO94 bearing pMPO1004
were induced as described before. After 4 h cells were detached by
trypsin treatment, washed twice with PBS and then resuspended
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on 100 ml lysis buffer [39] and kept on ice for 30 minutes. The cell
lysate was centrifuged at 20,000 g for 10 minutes, the supernatant
was retired and stored, whereas the pellet was washed with 1 ml of
PBS and finally resuspended in an original volume of lysis buffer
(100 ml). Protein concentrations were determined by the BCA
protocol (Sigma) and 20 mg of protein from the pellet and an
equivalent volume of supernatant were loaded for SDS-PAGE.
After electrophoresis and Western blotting, transference of
immunoreactive products to anti-HA were detected by the
enhanced chemiluminescence system (Thermo Scientific) and
quantified on a Typhoon 9410 scanner using the ImageQuant
software (Amersham). DnaK was used as a control to confirm the
absence of bacteria in the supernatant.
Supporting Information
Table S1 Strains and plasmids used in this work.
(DOC)
Data S1 Construction of expression vectors, lacZ fu-
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